Annual CAPEX
$808.00 K
-$11.01 M-93.16%
31 December 2023
Summary:
Adverum Biotechnologies annual capital expenditures is currently $808.00 thousand, with the most recent change of -$11.01 million (-93.16%) on 31 December 2023. During the last 3 years, it has fallen by -$11.04 million (-93.18%). ADVM annual CAPEX is now -95.80% below its all-time high of $19.25 million, reached on 31 December 2019.ADVM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$221.00 K
+$205.00 K+1281.25%
30 September 2024
Summary:
Adverum Biotechnologies quarterly capital expenditures is currently $221.00 thousand, with the most recent change of +$205.00 thousand (+1281.25%) on 30 September 2024. Over the past year, it has dropped by -$274.00 thousand (-55.35%). ADVM quarterly CAPEX is now -97.36% below its all-time high of $8.37 million, reached on 31 December 2019.ADVM Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$519.00 K
-$274.00 K-34.55%
30 September 2024
Summary:
Adverum Biotechnologies TTM capital expenditures is currently $519.00 thousand, with the most recent change of -$274.00 thousand (-34.55%) on 30 September 2024. Over the past year, it has dropped by -$282.00 thousand (-35.21%). ADVM TTM CAPEX is now -97.63% below its all-time high of $21.89 million, reached on 30 June 2020.ADVM TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADVM CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -93.2% | -55.4% | -35.2% |
| 3 y3 years | -93.2% | -96.1% | -95.8% |
| 5 y5 years | -0.1% | -96.4% | -95.3% |
ADVM CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -94.7% | at low | -96.6% | +1281.3% | -97.5% | at low |
| 5 y | 5 years | -95.8% | at low | -97.4% | +1281.3% | -97.6% | at low |
| alltime | all time | -95.8% | at low | -97.4% | +1281.3% | -97.6% | +1004.3% |
Adverum Biotechnologies CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $221.00 K(+1281.3%) | $519.00 K(-34.6%) |
| June 2024 | - | $16.00 K(-82.2%) | $793.00 K(-2.5%) |
| Mar 2024 | - | $90.00 K(-53.1%) | $813.00 K(+0.6%) |
| Dec 2023 | $808.00 K(-93.2%) | $192.00 K(-61.2%) | $808.00 K(+0.9%) |
| Sept 2023 | - | $495.00 K(+1275.0%) | $801.00 K(-29.1%) |
| June 2023 | - | $36.00 K(-57.6%) | $1.13 M(-85.0%) |
| Mar 2023 | - | $85.00 K(-54.1%) | $7.53 M(-36.3%) |
| Dec 2022 | $11.82 M(-21.9%) | $185.00 K(-77.5%) | $11.82 M(-26.1%) |
| Sept 2022 | - | $824.00 K(-87.2%) | $15.98 M(-23.4%) |
| June 2022 | - | $6.43 M(+47.1%) | $20.88 M(+15.4%) |
| Mar 2022 | - | $4.37 M(+0.5%) | $18.09 M(+19.6%) |
| Dec 2021 | $15.12 M(+27.7%) | $4.35 M(-23.9%) | $15.12 M(+23.9%) |
| Sept 2021 | - | $5.72 M(+56.8%) | $12.20 M(+27.6%) |
| June 2021 | - | $3.65 M(+159.8%) | $9.57 M(+5.9%) |
| Mar 2021 | - | $1.40 M(-2.0%) | $9.04 M(-23.7%) |
| Dec 2020 | $11.84 M(-38.5%) | $1.43 M(-53.5%) | $11.84 M(-36.9%) |
| Sept 2020 | - | $3.08 M(-1.1%) | $18.78 M(-14.2%) |
| June 2020 | - | $3.12 M(-25.9%) | $21.89 M(+2.9%) |
| Mar 2020 | - | $4.21 M(-49.7%) | $21.27 M(+10.5%) |
| Dec 2019 | $19.25 M | $8.37 M(+35.2%) | $19.25 M(+74.5%) |
| Sept 2019 | - | $6.19 M(+147.9%) | $11.03 M(+115.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | $2.50 M(+14.2%) | $5.11 M(+83.9%) |
| Mar 2019 | - | $2.19 M(+1292.4%) | $2.78 M(+243.5%) |
| Dec 2018 | $809.00 K(-20.4%) | $157.00 K(-41.9%) | $809.00 K(+7.9%) |
| Sept 2018 | - | $270.00 K(+62.7%) | $750.00 K(+12.6%) |
| June 2018 | - | $166.00 K(-23.1%) | $666.00 K(-31.3%) |
| Mar 2018 | - | $216.00 K(+120.4%) | $969.00 K(-4.6%) |
| Dec 2017 | $1.02 M(-57.9%) | $98.00 K(-47.3%) | $1.02 M(-44.8%) |
| Sept 2017 | - | $186.00 K(-60.3%) | $1.84 M(-8.7%) |
| June 2017 | - | $469.00 K(+78.3%) | $2.02 M(-21.0%) |
| Mar 2017 | - | $263.00 K(-71.5%) | $2.55 M(+5.8%) |
| Dec 2016 | $2.41 M(-19.4%) | $924.00 K(+155.2%) | $2.41 M(+43.9%) |
| Sept 2016 | - | $362.00 K(-63.9%) | $1.68 M(-36.3%) |
| June 2016 | - | $1.00 M(+723.0%) | $2.63 M(-2.6%) |
| Mar 2016 | - | $122.00 K(-35.1%) | $2.70 M(-9.7%) |
| Dec 2015 | $2.99 M(+217.3%) | $188.00 K(-85.7%) | $2.99 M(-5.6%) |
| Sept 2015 | - | $1.32 M(+22.8%) | $3.17 M(+62.1%) |
| June 2015 | - | $1.07 M(+161.3%) | $1.95 M(+49.5%) |
| Mar 2015 | - | $411.00 K(+12.9%) | $1.31 M(+38.6%) |
| Dec 2014 | $943.00 K | $364.00 K(+246.7%) | $943.00 K(+62.9%) |
| Sept 2014 | - | $105.00 K(-75.4%) | $579.00 K(+22.2%) |
| June 2014 | - | $427.00 K(+808.5%) | $474.00 K(+908.5%) |
| Mar 2014 | - | $47.00 K | $47.00 K |
FAQ
- What is Adverum Biotechnologies annual capital expenditures?
- What is the all time high annual CAPEX for Adverum Biotechnologies?
- What is Adverum Biotechnologies annual CAPEX year-on-year change?
- What is Adverum Biotechnologies quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Adverum Biotechnologies?
- What is Adverum Biotechnologies quarterly CAPEX year-on-year change?
- What is Adverum Biotechnologies TTM capital expenditures?
- What is the all time high TTM CAPEX for Adverum Biotechnologies?
- What is Adverum Biotechnologies TTM CAPEX year-on-year change?
What is Adverum Biotechnologies annual capital expenditures?
The current annual CAPEX of ADVM is $808.00 K
What is the all time high annual CAPEX for Adverum Biotechnologies?
Adverum Biotechnologies all-time high annual capital expenditures is $19.25 M
What is Adverum Biotechnologies annual CAPEX year-on-year change?
Over the past year, ADVM annual capital expenditures has changed by -$11.01 M (-93.16%)
What is Adverum Biotechnologies quarterly capital expenditures?
The current quarterly CAPEX of ADVM is $221.00 K
What is the all time high quarterly CAPEX for Adverum Biotechnologies?
Adverum Biotechnologies all-time high quarterly capital expenditures is $8.37 M
What is Adverum Biotechnologies quarterly CAPEX year-on-year change?
Over the past year, ADVM quarterly capital expenditures has changed by -$274.00 K (-55.35%)
What is Adverum Biotechnologies TTM capital expenditures?
The current TTM CAPEX of ADVM is $519.00 K
What is the all time high TTM CAPEX for Adverum Biotechnologies?
Adverum Biotechnologies all-time high TTM capital expenditures is $21.89 M
What is Adverum Biotechnologies TTM CAPEX year-on-year change?
Over the past year, ADVM TTM capital expenditures has changed by -$282.00 K (-35.21%)